Morning Briefing
Summaries of health policy coverage from major news organizations
It's Imperative For Congress To Kick Work On Opioid Crisis Into 'High Gear,' Rep. Walden Says
House Energy and Commerce Committee chairman Rep. Greg Walden (R-Ore.) is calling on lawmakers to "redouble" efforts to address the opioid epidemic as the committee prepares to hold a hearing on the crisis next month. 鈥淧resident Donald Trump recently declared the epidemic a national emergency,鈥 Walden wrote in a Morning Consult op-ed published Tuesday. (Roubein, 9/12)
Opioids aren鈥檛 widely overused by the general population, as often presumed. Rather, more than three-quarters of opioid prescriptions are written for just 10 percent of patients, according to an analysis by Dr. Eric Sun of Stanford University Medical Center, published in the latest issue of the Annals of Internal Medicine. (Krieger, 9/12)
And more on the crisis聽鈥
A controversial proposal to allow certain California counties and cities to establish sites where people could inject drugs without legal consequences stumbled聽in the state Senate on Tuesday night. The measure, by Assemblywoman Susan Talamantes Eggman (D-Stockton), would establish a first-in-the-nation program in which users of heroin and other intravenous drugs could inject in聽settings with clean needles and under the supervision of trained staff. The goal: to stave off overdoses in an era in which heroin use is on the rise. (Mason, 9/12)
Cincinnati and Hamilton County will soon spend another $400,000 on the fight against heroin addiction, investing in public outreach, a hotline for drug users seeking help and life-saving medical treatment for people who overdose. City council members and county commissioners agreed weeks ago to increase spending by an additional $200,000 each, but they talked Tuesday for the first time about how those tax dollars will be spent. (Horn, 9/12)
U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role in the death of 32-year-old Sarah Fuller in Camden County last year. ... Also聽testifying at the hearing聽was a pain patient named聽Jeffrey Buchalter, a veteran of four tours in Iraq, who now lives in Maryland. Insys allegedly paid his physician $34,000 as part of a 鈥渟peakers program鈥 about Subsys, after which his doctor prescribed inappropriate amounts of the drug, making him into what he called a 鈥渇ull-blown addict.鈥 (Sapatkin, 9/12)